Description
Notch Signaling Antibody Sampler Pack (ABSP013)
The Notch Signaling Antibody Sampler Pack from Assay Genie brings together 7 rigorously validated antibodies covering the key nodes of this pathway in a convenient 20µL trial format. It is designed to let researchers interrogate an entire signalling axis in a single, cost-effective pack, then scale up to full-size formats for the targets that matter most to their work.
| Pack Name: | Notch Signaling Antibody Sampler Pack |
| SKU: | ABSP013 |
| Research Area: | Cancer |
| Targets Included: | 7 |
| Format: | 7 × 20µL |
| Targets: | Notch1, Notch2, DLL4, Hes1, Hey1, Presenilin1, Notch3 |
| Target | Antibody | SKU | Host | Reactivity | Applications | Size |
|---|---|---|---|---|---|---|
| Notch1 | Anti-Notch1 [ARC0285] Monoclonal Antibody | CAB19090-20 | Rabbit | Human, Mouse | WB IP ELISA | 20µL |
| Notch2 | Anti-NOTCH2 Antibody | CAB24877-20 | Rabbit | Human, Mouse, Rat | WB IF/ICC ELISA | 20µL |
| DLL4 | Anti-DLL4 Antibody | CAB12943-20 | Rabbit | Human, Mouse, Rat | WB ELISA | 20µL |
| Hes1 | Anti-HES1 [ARC0513] Monoclonal Antibody | CAB0925-20 | Rabbit | Mouse, Rat | WB IHC-P IP ELISA | 20µL |
| Hey1 | Anti-HEY1 Antibody | CAB16110-20 | Rabbit | Human, Mouse, Rat | WB IF/ICC ELISA | 20µL |
| Presenilin1 | Anti-Presenilin 1 Monoclonal Antibody | CAB19103-20 | Rabbit | Human, Mouse, Rat | WB ELISA | 20µL |
| Notch3 | Anti-NOTCH3 Antibody | CAB13522-20 | Rabbit | Human, Mouse, Rat | WB IHC-P ELISA | 20µL |
Notch signalling mediates juxtacrine cell-fate decisions: ligand binding (Jagged, DLL) triggers gamma-secretase cleavage of the Notch receptor, releasing the intracellular domain (NICD) to activate HES/HEY target genes. The pathway influences stem-cell maintenance, differentiation and oncogenesis.
| Pack Format: | 7 antibodies, 20µL each (trial size) |
| Storage: | Store at -20°C |
| Shelf Life: | 12 months |
| Shipping: | Gel pack |
Every antibody in this sampler pack is also available individually in full 100µL size for follow-on experiments and assay scale-up.